Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 3Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 10Esophageal Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma Of Esophagus 4Sarcoma 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Neoplasms 2Melanoma 2Vomiting 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Malignant mesenchymal tumor 1

Interventions

Dexamethasone 112Bortezomib 61Lenalidomide 49Cyclophosphamide 49Calcium Dobesilate 43pomalidomide 32Melphalan 31fludarabine 25Filgrastim 25carfilzomib 22fludarabine phosphate 21daratumumab 20Granulocyte Colony-Stimulating Factor 16Whole-Body Irradiation 15Antilymphocyte Serum 15dexamethasone acetate 14Mycophenolic Acid 14Thalidomide 13Tacrolimus 13Cyclosporine 13Busulfan 13Peripheral Blood Stem Cell Transplantation 12ixazomib 11dexamethasone 21-phosphate 10auricularum 10pembrolizumab 9Radiotherapy 9Etoposide 9belantamab mafodotin 8Rituximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Multiple Myeloma × Neoadjuvant Therapy × Clear all
NCT00574080 2017-11-20

UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide

University of Arkansas

Phase 3 Terminated
20 enrolled 7 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡